Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Sonnet BioTherapeutics Holdings, Inc. - Common Stock (NQ:SONN)

1.254 +0.004 (+0.34%)
Streaming Delayed Price Updated: 3:59 PM EDT, Apr 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sonnet BioTherapeutics Holdings, Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Mid-Day Market Update: Dow Drops 150 Points; Bluejay Diagnostics Shares Jump
U.S. stocks traded lower midway through trading, with the Dow Jones dropping 150 points on Thursday. 
Via Benzinga
36 Stocks Moving In Thursday's Mid-Day Session
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) jumped 65% to $0.6382. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Sonnet Shares Surge As FDA Clears Its First Human Trial For Solid Tumor Candidate
Via Benzinga
Sonnet BioTherapeutics Announces Positive Results from a Preclinical Combination Study of SON-1010 with anti-PD1 Checkpoint Inhibition
PRINCETON, NJ / ACCESSWIRE / June 9, 2022 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs,... 
From Sonnet BioTherapeutics, Inc.
Via AccessWire
Sonnet BioTherapeutics Announces Adjournment of Annual Meeting Due to Lack of Quorum
PRINCETON, NJ / ACCESSWIRE / June 2, 2022 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs,... 
From Sonnet BioTherapeutics, Inc.
Via AccessWire
Sonnet BioTherapeutics Provides Fiscal Year 2022 Second Quarter Business and Earnings Update
- IND for SON-1010 cleared by FDA with first patient dosed in trial for advanced solid tumors - SON-080 on track to begin clinical studies by mid-2022 - Preclinical data for SON-1010, SON-1210, and... 
From Sonnet BioTherapeutics, Inc.
Via AccessWire
Exposures Product Safety
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Rise and shine, trader! Join me today as we break down all the news behind the biggest pre-market stock movers for Wednesday! 
Via InvestorPlace
Sonnet BioTherapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of SON-1010 for Advanced Solid Tumors
PRINCETON, NJ / ACCESSWIRE / April 13, 2022 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic drugs, announced today that dosing has... 
From Sonnet BioTherapeutics, Inc.
Via AccessWire
Sonnet BioTherapeutics Announces Preclinical Data Supporting Its Bispecific Interleukin Candidates at the American Association for Cancer Research (AACR) 2022 Annual Meeting
PRINCETON, NJ / ACCESSWIRE / April 8, 2022 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic drugs, announced today that data from... 
From Sonnet BioTherapeutics, Inc.
Via AccessWire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Good morning, trader! Get ready for another busy day of trading with our breakdown of the biggest pre-market stock movers for Friday! 
Via InvestorPlace
16 Stocks Moving in Friday's Pre-Market Session
Gainers Biofrontera Inc. (NASDAQ: BFRI) rose 34.5% to $5.44 in pre-market trading. ENDRA Life Sciences Inc. (NASDAQ: NDRA) rose 31.9% to $0.5891 in pre-market trading after... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Aesthetic Medical Intl (NASDAQ:AIH) shares increased by 27.8% to $1.77 during Friday's regular session. The current volume of 149.1K shares is 551.4% of... 
Via Benzinga
58 Biggest Movers From Friday
Gainers BEST Inc. (NYSE: BEST) shares gained 73.6% to close at $1.00. DiDi Global Inc. (NYSE: DIDI) shares jumped 59.8% to settle at $4.09 on Friday. Zhihu Inc. (NYSE: ZH)... 
Via Benzinga
45 Stocks Moving In Friday's Mid-Day Session
Gainers Grom Social Enterprises, Inc. (NASDAQ: GROM) jumped 62.4% to $1.5500. DiDi Global Inc. (NYSE: DIDI) shares climbed 46% to $3.73. Kidpik Corp. (NASDAQ: PIK) shares... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Sunshine Biopharma (NASDAQ:SBFM) stock increased by 15.5% to $3.5 during Friday's pre-market session. The company's market cap stands at $15.6 million.... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Good morning, trader! Let's start off the final day of the workweek right with a breakdown of the biggest pre-market stock movers for Friday! 
Via InvestorPlace
25 Stocks Moving in Friday's Pre-Market Session
Gainers Grom Social Enterprises, Inc. (NASDAQ: GROM) rose 60.5% to $1.53 in pre-market trading. StoneCo Ltd. (NASDAQ: STNE) shares rose 23.7% to $11.90 in pre-market trading... 
Via Benzinga
22 Stocks Moving in Thursday's Pre-Market Session
Gainers TD Holdings, Inc. (NASDAQ: GLG) rose 81.2% to $0.43 in pre-market trading after the company reported FY21 results. Orphazyme A/S (NASDAQ: ORPH) shares rose 35.1% to $0.... 
Via Benzinga
80 Biggest Movers From Yesterday
Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares gained 86.7% to close at $0.5150 on Wednesday after the company announced FDA clearance of its IND for SON-... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Sonnet BioTherapeutics (NASDAQ:SONN) shares rose 114.0% to $0.59 during Wednesday's regular session. As of 13:30 EST, this security is trading at a volume of... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Sonnet BioTherapeutics (NASDAQ:SONN) stock rose 85.6% to $0.51 during Wednesday's pre-market session. The company's market cap stands at $30.8 million.... 
Via Benzinga
Sonnet BioTherapeutics Announces FDA Clearance of Its IND for SON-1010 for the Treatment of Advanced Solid Tumors
- Represents Sonnet's first IND cleared - Phase 1 trial initiation expected in 2Q22 PRINCETON, NJ / ACCESSWIRE / March 16, 2022 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the... 
From Sonnet BioTherapeutics, Inc.
Via AccessWire
Exposures Product Safety
Sonnet BioTherapeutics Announces Abstract Accepted for Presentation in a Poster Session at the AACR 2022 Annual Meeting
PRINCETON, NJ / ACCESSWIRE / February 9, 2022 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic... 
From Sonnet BioTherapeutics, Inc.
Via AccessWire
68 Biggest Movers From Yesterday
Gainers ECMOHO Limited (NASDAQ: MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday. Imperial Petroleum Inc. (NASDAQ: IMPP) shares jumped 39.2% to... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Second Sight Medical (NASDAQ:EYES) stock increased by 7.8% to $1.51 during Tuesday's pre-market session. The market value of their outstanding shares is at $59... 
Via Benzinga
Sonnet BioTherapeutics Provides Fiscal Year 2022 First Quarter Business and Earnings Update
- SON-1010 and SON-080 on track to initiate clinical studies during the second quarter of 2022 - Completed R&D manufacturing for SON-1210 non-GLP toxicity study in non-human primates, with study... 
From Sonnet BioTherapeutics, Inc.
Via AccessWire
Exposures Product Safety
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Enveric Biosciences (NASDAQ:ENVB) shares increased by 12.9% to $0.7 during Monday's pre-market session. The market value of their outstanding shares is at $22.... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Syros Pharmaceuticals (NASDAQ:SYRS 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Indaptus Therapeutics (NASDAQ:INDP 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.